Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Illinois Wellness Insider.
Press releases published on August 12, 2025
Dr. Sam Speron Highlights Medical and Emotional Impacts of Otoplasty in New Discussion
EIN Presswire
·
August 12, 2025
Dr. Sam Speron Highlights Medical and Emotional Impacts of Otoplasty in New Discussion CHICAGO, IL, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- Dr. Sam Speron, a board-certified plastic and reconstructive surgeon, highlights the transformative …
argenx and Tennis Legend Monica Seles Team Up to Raise Awareness of Myasthenia Gravis
GlobeNewswire
·
August 12, 2025
Seles speaks out about her diagnosis with MG, a chronic autoimmune disease that causes muscle weakness, which can be severe and significantly impact daily life Partnership with Seles will highlight the ‘Go for Greater’ MG patient support initiative at the …
Rapid Micro Biosystems Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 12, 2025
Reports second quarter 2025 total revenue of $7.3 million, representing 10% growth compared to the second quarter of 2024. Second quarter 2025 recurring revenue increased 15% compared to the second quarter of 2024. Reports second quarter gross margin of 4% …
Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.
GlobeNewswire
·
August 12, 2025
$20 million drawn down at closing, with access to up to an additional $25 million Strengthens Company’s financial position and reinforces ability to achieve positive cash flow LEXINGTON, Mass., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. …
Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress
GlobeNewswire
·
August 12, 2025
--Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal side effects compared to semaglutide alone-- --Company …
Mabylon AG Raises CHF 30 Million to Advance Peanut Allergy Lead Program MY006 to Clinical Proof-of-Concept
GlobeNewswire
·
August 12, 2025
Funding combines equity investment and convertible loan Focus on best-in-class, clinical-stage peanut allergen neutralizing antibody Further potential for developing Mabylon’s discovery and pre-clinical pipeline programs Dr. Thomas Hecht has joined Board …
Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
GlobeNewswire
·
August 12, 2025
ZUG, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic conditions with significant unmet medical needs, …
Rakovina Therapeutics and NanoPalm Ltd. Sign Letter of Intent to Form Joint Venture Leveraging AI-Discovered Oncology Therapies and Novel Lipid Nanoparticle Delivery Technologies
GlobeNewswire
·
August 12, 2025
VANCOUVER, British Columbia and RIYADH, Saudi Arabia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through artificial …
Phonak unveils Virto R Infinio: the compact rechargeable hearing aid designed for today's active lifestyle
GlobeNewswire
·
August 12, 2025
STÄFA, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Phonak, a global leader in hearing care solutions is excited to introduce the Virto R Infinio, its most compact rechargeable custom in-the-ear (ITE) hearing aid powered by the advanced Infinio …
Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations
GlobeNewswire
·
August 12, 2025
MEDIA RELEASE Sandoz signs 10-year virtual PPA with Elawan Energy for new 150 MW solar projects in Spain Will cover nearly 90% of electricity demand for European operations Concrete step to support global Sandoz decarbonization efforts and sustainability …
Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
GlobeNewswire
·
August 12, 2025
Total revenues of €97.6 million compared to €70.8 million in the first half of 2024 Cash and cash equivalents of €161.3 million at end of June 2025 Further clinical and regulatory progress 2025 financial outlook confirmed Saint-Herblain (France), August 12 …
Valneva publie ses résultats financiers du premier semestre 2025 et fait un point sur ses activités
GlobeNewswire
·
August 12, 2025
Chiffre d’affaires de 97,6 millions d’euros contre 70,8 millions d’euros au premier semestre 2024 Trésorerie de 161,3 millions d’euros à fin juin 2025 Poursuite des avancées cliniques et réglementaires Confirmation des perspectives 2025 Saint-Herblain ( …
iPETcertum™ by Claritas, Developed with Cutting-Edge Technology for Enhancement, Automated Segmentation and Accurate Quantification in PET, PET-CT/MRI Scans, Receives FDA Clearance
GlobeNewswire
·
August 12, 2025
LONDON and NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Claritas NucMed Technologies Ltd (Claritas), a healthcare technology company specializing in state-of-the-art signal processing, quantification and AI technologies for the nuclear medicine industry, is …
Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering
GlobeNewswire
·
August 12, 2025
JUPITER, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) (“Ligand”) announced today the pricing of $400.0 million aggregate principal amount of 0.75% convertible senior notes due 2030 (the “notes”) in a private …